commonly known as pau santo. A decoction of the stems is used to treat several tropical diseases including schistosomasis, leishmaniasis, malaria and fungal and bacterial infections. [1] High performance liquid chromatography (HPLC) analysis of the hydroethanolic extract (HE) and the dichloromethane (DcM) semipurified fraction of K. coriacea stems detected the presence of xanthones, triterpenes and their biphenyl derivatives. [2, 3] Previous studies conducted in our laboratory showed that chronic administration of the HE and the DcM semipurified fraction of K. coriacea stems by gavage reduced the immobility time in rats subjected to the forced swimming test (FST) suggesting an antidepressant-like effect. [3, 4] Drugs acting on the serotonin (5-HT, 5-hydroxytryptamine) system have been shown to be effective in the treatment of depressive disorders. [5] Somatodendritic 5-HT 1A autoreceptors a particularly important role in this antidepressant activity. These receptors are considered to be the principal inhibitory regulators of 5-HT neuronal activity, playing an important role in the physiological control of the ascending 5-HT pathway. Stimulation of these 5-HT 1A receptors in the DRN reduces the firing of 5-HT neurons and produces an anti-5-HT effect through the reduction in 5-HT release. [6] [7] [8] A delay of usually 2-4 weeks in the onset of antidepressant activity [5, 6] is attributed to activation of the inhibitory somatodendritic 5-HT 1A autoreceptors located in the DRN. This DRN somatodendritic 5-HT 1A autoreceptor-mediated inhibition of antidepressant activity can be induced by exogenously applied 5-HT, 5-HT 1A agonists or by acute administration of 5-HT re-uptake inhibitors. All these factors inhibit neuronal firing and consequently, decrease 5-HT release in different areas of the forebrain; and may hinder the therapeutic efficacy of an antidepressant. After continued stimulation, these feedback mechanisms become desensitized and the enhanced 5-HT availability is able to enhance 5-HT neurotransmission. [8] Current strategies aim to improve the efficacy of antidepressant drugs including the co-administration of 5-HT 1A and / or 5-HT 1A/1B autoreceptor antagonists. These 5-HT antagonists can facilitate the antiimmobility effect of subeffective doses of antidepressant drugs in rats and mice in the FST [9] and thus, accelerate the effects of these drugs in patients with major depression. [10] gel) and eluted with hexane (1000 mL), dichloromethane (1000 mL), ethyl acetate (1000 mL), acetone (1000 mL) and methanol/ water (1000 mL), yielding five fractions (F1: 1.8 g), (F2: 28.6 g), (F3: 21.6 g), (F4: 11.1 g) and (F5: 29.5 g) respectively. [Patent application # 001342 with the National Patents Institute (INPI) on October 9, 2002].
Stereotaxic operations
Rats anaesthetized with sodium thiopental (Thiopentax ® , 45 mg/kg i.p, Cristália) and local anesthetic agents (2% xylocaine + adrenaline) were positioned in the stereotaxic frame and cannulated using a guide cannula stereotaxically placed at the The FST is one of the most frequently used screening tests DRN. The stereotaxic coordinates were: AP = -7.1 mm, L = 4.0 for antidepressant drugs in rodents. It shows great sensitivity mm, DV = 5.3 mm, from the Paxinos and Watson atlas [12] with to different antidepressant classes and permits determination reference to bregma for the tip of the 15 mm-long stainless-steel of the neurobiological mechanisms underlying stress and cannula (0.6 mm external diameter) positioned 0.2 mm above the antidepressant responses. Different classes of antidepressant DRN. The cannula was inserted into the DRN at an angle of 34º drugs are effective in decreasing immobility time in the FST. [11] to the horizontal plane to avoid penetration of the midline sinus In this study, we examined the involvement of 5-HT and the brain aqueducts. The stainless-steel guide cannulas were neurotransmission, particularly that mediated by somatodendritic fixed to the skull with stainless-steel screws and self-polymerising autoreceptors in the antidepressant-like effect of the DcM acrylate resin and were closed with a stainless-steel wire to semipurified fraction of a K. coriacea stem extract. We assessed prevent obstruction. The animals were allowed to recover for the effects of chronic administration of the test substance (DcM five or six days before the experiments. fraction) alone or in combination with intraDRN microinjections Microinjections of 5-HT1A/1B agonists or antagonists in rats subjected to the The rats were given microinjections while they were awake. FST or open field test (OFT). An effective dose of the DcM A 17-mm needle (0.3 mm outer diameter) was inserted into fraction was given along with an intraDRN microinjection of the guide cannula so that it extended 0.2 mm beyond the agonist, (+) 8-hydroxy-2-di-n-propylamino-tetralin cannula tip. The microinjection needle was connected to a (8-OH-DPAT) while a subactive dose of the DcM fraction was 10 µL microsyringe (Hamilton 71-RN, USA) through a filled given in combination with either the selective 5-HT 1A antagonist, polyethylene tube (PE 10). The polyethylene tube was filled or the 5HT 1A/1B/ ß adrenergic antagonist, (-)-pindolol.
either with the drugs or with the control substance by aspiration.
Materials and Methods
Solutions were injected with a microinfusion pump (Insight Equipments, Brazil) at a flow rate of 0.2 µl/30 s. After each infusion, the needle was left in place for 30 s before being Male Wistar rats, each weighing 180-200 g (Central removed to allow the drug to be absorbed. Biotério, University of Maringá-UEM) were used. The rats Treatments were housed in groups of four per cage and maintained on The DcM fraction from K. coriacea stems was dissolved in a 12 h light/dark cycle (lights on at 7:00 h) under controlled a vehicle (water + 5% dimethylsulfoxide, DMSO). Solutions of temperature (22 ± 1ºC), with freely available food and water.
(+)-8-OH-DPAT hydrobromide (Sigma-RBI), (-)-pindolol (SigmaAll experiments were carried out between 8:00 and 12:00 h. The RBI) and WAY (Sigma-RBI) were all dissolved in saline. To coriacea were exhaustively extracted by maceration with 38 L of ethanol/water (9:1) at room temperature for seven days, yielding 167.3 g of extract after evaporation of the solvents and lyophilization. After lyophilization, the crude HE extract from K. coriacea stems (167.3 g) was stored in a freezer at -15°C. In order to assess the stability of the DcM fraction, comparative chromatographic analyses were conducted before chronic treatment of the animals. The HE extract (110.6 g) was submitted to vacuum column chromatography (208.3 g silica HT 1A ligands (WAY 100635 , (-)-pindolol or (+)-8-OH-DPAT) or saline. The doses of the DcM were based on previous studies conduced in our laboratory. [3] (+) 8-OH-DPAT, WAY 100635 and (-) pindolol doses used in our study were based in another studies. [13] [14] [15] [16] 
Forced swimming test (FST) and open field test (OFT)
Rats were individually forced to swim in an open cylindrical container (diameter 30 cm, height 60 cm), containing water of 45 cm depth at 25 ± 1ºC. The test employed is essentially similar to that described by Porsolt et al. [11] except for the water level. The water level has been increased (45 cm) in order to increase the sensitivity of the test. The rats lack a sense of the water's depth and their tails do not touch the bottom of the cylinder. This procedural modification is consistent with the practice of other authors [17] and should be considered the present standard method. Animals were exposed to a pretest for 15 min, 24 h prior to the 5 min swim test. Each animal was considered immobile when it ceased to struggle and swim and remained floating in the water, only moving to keep its head above water. After the test, the animals were removed from the water, dried by the experimenter and placed in cages. After 24 h, the same animals were individually placed in the OFT (40 x 40 x 40 cm) square field, which was divided into 25 identical squares. The rats were observed to evaluate locomotor activity measured by the total number of crossings in the squares. After 30 s of habituation, the 5 min swim session in the FST or the 5 min locomotion session in the OFT was videotaped out at the end of the behavioral experiments. The animals were anaesthetized by the intraperitoneal route (i.p.) with sodium
Data are means ± SE, (n= 9-15) of intra-DRN (0.20 μL/30s) saline or 5-HT 1A in rats chronically treated with vehicle (water + 5% DMSO). *P<0.05 compared thiopental and their brains were perfused through the heart to control groups with saline followed by 10% formaldehyde solution before being removed for histological analysis. After fixation, the brains were sectioned into 50 µm-thick slices in the coronal plane on Table 2 a freezing microtome. The sites of the injections in the DRN were determined by comparing the sections with the Paxinos
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and Watson atlas. [12] If the injection site was located outside the in the FST DRN (20.0%), the animal was discarded.
5-HT 1A agonist

Data analysis
mg/kg
Results are expressed as the mean ± SE for each group.
(+)-8-OH-DPAT (µg)
One-way or two-way analysis of variance (ANOVA) followed by group. The addition of each dose of (+)-8-OH-DPAT reversed the on immobility time (s) in the FST and the crossings number antiimmobility effect produced by the DcM. in the OFT in rats chronically treated with vehicle (water Table 3 shows the results of the treatment with saline, + 5% DMSO). Table 3 Effects depression in rats. This result confirms previous dose-response curves obtained in our laboratory. These dose-response curves established the lowest active dose for chronic treatment effects and determined whether chronic administration was effective at doses that were ineffective after acute or subacute treatment with the DcM fraction from K. coriacea. [3] Thus, the DcM fraction was active in the FST when administered for 45 days at a dose of 5.0 mg/kg but not at a dose of 4.0 mg/kg. This antiimmobility effect of the DcM fraction does not reflect a general increase in motor activity because the same dose which induced an antidepressant-like effect did not increase mg/kg). *P<0.05 for differences between the WAY100635+DcM and control-, DcMlocomotion in the OFT. The antiimmobility effect detected after or WAY100635-treated groups. # P<0.05 for difference between the (-)-pindolol+DcM and DcM-treated group chronic but not after acute or subacute treatment of DcM in the FST is consistent with other findings. [18] Acute administration of selective 5-HT (serotonin) re-uptake inhibitors (SSRIs) and other antidepressant drugs induces an with DcM (4.0 mg/kg) as compared to the control, increase in the concentration of 5-HT in the vicinity of 5-HT cell DcM-or WAY 100635 -treated groups.
bodies in midbrain raphe nuclei. It also triggers activation of Table 4 shows the response of the number of crossings in 5-HT 1A somatodendritic autoreceptors, thus inhibiting the firing the OFT to treatment with saline or (+)-8-OH-DPAT (0.20 or activity of the 5-HT neurons and reducing the release of 5-HT in 0.33 µg) in rats chronically treated with vehicle or DcM (5.0 the forebrain. [6] [7] [8] Studies have shown that intraraphe or systemic mg/kg) in the OFT. The two-way ANOVA shows an effect of (+)-administration of 5-HT antagonists, WAY antidepressant treatment in preclinical and clinical studies and / Table 5 shows the effect of treatment of (-)-pindolol (0.10 or to improve antidepressant therapy in resistant patients. Pindolol is also known to block ß-adrenoceptors but considering 0.04, P = 0.85) or of the association of WAY 100635 X DcM (F (1.30) the reports of increased incidence of depressive disorders due to = 0.02, P = 0.89).
ß-adrenergic blockers, it is unlikely that ß-adrenoceptor inhibition enhances the efficacy of antidepressant drugs. [22] Table 4 Effects of a combination of the DcM fraction with intraDRN microinjection of (+) 8-OH-DPAT on the number of crossings in the OFT Table 5 Effects ) .
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